Authors: Samdal, IA Sletten, K Olsen, KE Westermark, P

Citation: Ia. Samdal et al., AL 366 - a glycosylated protein of kappa 1b origin in a patient with systemic amyloidosis of predominantly non-parenchymatous distribution, AMYLOID, 8(2), 2001, pp. 111-114

Authors: Ilum, L Bak, M Olsen, KE Kryh, D Berg, V Axelsson, CK

Citation: L. Ilum et al., Sentinel node localization in breast cancer patients using intradermal dyeinjection, ACTA ONCOL, 39(3), 2000, pp. 423-428

Authors: Olsen, KE Sletten, K Sandgren, O Olsson, H Myrvold, K Westermark, P

Citation: Ke. Olsen et al., What is the role of giant cells in AL-amyloidosis?, AMYLOID, 6(2), 1999, pp. 89-97

Authors: Olsen, KE Sletten, K Westermark, P

Citation: Ke. Olsen et al., The use of subcutaneous fat tissue for amyloid typing by enzyme-linked immunosorbent assay, AM J CLIN P, 111(3), 1999, pp. 355-362

Authors: Gentile, M Jungestrom, MB Olsen, KE Soderkvist, P Wingren, S

Citation: M. Gentile et al., p53 and survival in early onset breast cancer: Analysis of gene mutations,loss of heterozygosity and protein accumulation, EUR J CANC, 35(8), 1999, pp. 1202-1207

Authors: Vitak, B Olsen, KE Manson, JC Arnesson, LG Stal, O

Citation: B. Vitak et al., Tumour characteristics and survival in patients with invasive interval breast cancer classified according to mammographic findings at the latest screening: a comparison of true interval and missed interval cancers, EUR RADIOL, 9(3), 1999, pp. 460-469